APLT News and Press, Applied Therapeutics Inc. From 02/10/21

NEW YORK, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today...

Applied Therapeutics (APLT) rose yesterday after the company announced that the FDA lifted hold for ACTION-Galactosemia Kids pediatric clinical study for AT-007.The company expects to immediately resume the study with a target of completing the enrollment within weeks, as patients who were al...

Gainers: Viela Bio VIE +53%, Dynavax Technologies DVAX +36%, Applied Therapeutics (APLT) +29%, BioCryst Pharmaceuticals BCRX +28%, Vaxart (VXRT) +26%.Losers: Matinas BioPharma MTNB -33%, Concert Pharmaceuticals CNCE -31%,&#...

FDA Clinical Hold Lifted NEW YORK, Feb. 01, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, to...

APLT looks like a promising biopharma developing important medicine. However, it had been under a short attack last year, and certain alleged actions by the company did not help matters. There's also a clinical hold in place; if it is resolved soon, this may become interesting. ...

Larimar Therapeutics ([[LRMR]] -3.4%), Avadel Pharmaceuticals ([[AVDL]] +1.7%) and Applied Therapeutics ([[APLT]] +2.5%) have been selected to be included in the NASDAQ Biotechnology Index.The addition to the index will become effective prior to market open on Monday, December 21.In compariso...

NEW YORK, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced that the Company wa...

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the launch of Gal...

NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced magnetic resonance ...

Gainers: Akers Biosciences (AKER) +45%, Cidara Therapeutics (CDTX) +29%, Five Prime Therapeutics (FPRX) +24%, Zhongchao (ZCMD) +22%, Vaxart (VXRT) +22%.Losers: Applied Therapeutics (APLT) -12%, Soliton (SOLY) -13%, Harmony ...